ARCHIVES

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

This article is from The Cancer Letter archive.

Vol. 19 No. 13 | March 26, 1993

Download PDF Visit The Full Archive

Related Articles

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

ONS Meeting Again With ASCO And AACR In San Francisco

April 28, 1989

NCI Programs: Institute Seeks White Papers On Technology

September 11, 1998

Panel Angered By Unreasonable Senate Committee Demands, Will Seek Meeting With Hatch On Probe

April 24, 1981

ASCO Proposes Principles For Future Debate on Medicaid

November 21, 2014

Nancy Davidson Elected ASCO President.

March 3, 2006